theory clinical_55_5
imports Main

begin

typedecl entity
typedecl event

consts
  Patient :: "entity ⇒ bool"
  Mutation :: "entity ⇒ bool"
  Pathogenic :: "entity ⇒ bool"
  PALBPALB2 :: "entity ⇒ bool"
  BindingPartner :: "entity ⇒ bool"
  Encodes :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Localises :: "event ⇒ bool"
  BRCA2 :: "entity ⇒ bool"
  Sites :: "entity ⇒ bool"
  DNADamage :: "entity ⇒ bool"
  To :: "entity ⇒ entity ⇒ bool"
  Links :: "event ⇒ bool"
  BRCA1 :: "entity ⇒ bool"
  HRRepair :: "entity ⇒ bool"
  In :: "entity ⇒ entity ⇒ bool"
  Molecules :: "entity ⇒ bool"
  Undamaged :: "entity ⇒ bool"
  Homologous :: "entity ⇒ bool"
  Repair :: "entity ⇒ bool"
  RAD51 :: "entity ⇒ bool"
  Homolog1 :: "entity ⇒ bool"
  Humans :: "entity ⇒ bool"
  Promotes :: "event ⇒ bool"
  Joining :: "event ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"
  Loss :: "entity ⇒ bool"
  Localisation :: "entity ⇒ bool"
  Disrupts :: "event ⇒ bool"
  Prevents :: "event ⇒ bool"
  Promoting :: "event ⇒ bool"
  HRR :: "entity ⇒ bool"
  Action :: "entity ⇒ bool"

(* Explanation 1: Patient with a pathogenic mutation in PALBPALB2 encodes a binding partner that localises BRCA2 to sites of DNA damage and links BRCA1 and BRCA2 in HR repair and DNA damage. *)
axiomatization where
  explanation_1: "∃x y z w v u t e1 e2 e3. Patient x ∧ Mutation y ∧ Pathogenic y ∧ PALBPALB2 y ∧ BindingPartner z ∧ Encodes e1 ∧ Agent e1 x ∧ Agent e1 z ∧ Localises e2 ∧ Agent e2 z ∧ BRCA2 w ∧ Sites v ∧ DNADamage v ∧ To w v ∧ Links e3 ∧ Agent e3 z ∧ BRCA1 u ∧ BRCA2 w ∧ HRRepair t ∧ DNADamage t ∧ In u t ∧ In w t"

(* Explanation 2: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)
axiomatization where
  explanation_2: "∃x y z w e1 e2. BRCA2 x ∧ Molecules y ∧ Undamaged y ∧ Homologous y ∧ Repair y ∧ RAD51 z ∧ Homolog1 z ∧ Humans w ∧ Promotes e1 ∧ Agent e1 x ∧ Joining e2 ∧ Agent e2 x ∧ Agent e2 y ∧ Via e2 z ∧ In x w"

(* Explanation 3: Loss of PALB2 disrupts the localisation of BRCA2 to sites of DNA damage, which directly prevents BRCA2 from promoting the joining of undamaged homologous repair molecules in HRR. *)
axiomatization where
  explanation_3: "∃x y z w e1 e2 e3. Loss x ∧ PALB2 x ∧ Localisation y ∧ BRCA2 y ∧ Sites z ∧ DNADamage z ∧ Disrupts e1 ∧ Agent e1 x ∧ Agent e1 y ∧ To y z ∧ Prevents e2 ∧ Agent e2 y ∧ Promoting e3 ∧ Agent e3 y ∧ Molecules w ∧ Undamaged w ∧ Homologous w ∧ Repair w ∧ HRR w ∧ Joining e3 ∧ Agent e3 w"

theorem hypothesis:
  assumes asm: "Loss x ∧ PALB2 x"
  (* Hypothesis: Loss of PALB2 prevents the action of BRCA2 in joining undamaged repair molecules in HRR *)
  shows "∃x y z e1 e2. Loss x ∧ PALB2 x ∧ Action y ∧ BRCA2 y ∧ Molecules z ∧ Undamaged z ∧ Repair z ∧ HRR z ∧ Prevents e1 ∧ Agent e1 x ∧ Agent e1 y ∧ Joining e2 ∧ Agent e2 y ∧ Agent e2 z"
proof -
  (* From the premise, we have the known information about the loss of PALB2. *)
  from asm have "Loss x ∧ PALB2 x" by blast
  (* Explanation 3 provides a logical relation Implies(E, F), which states that the loss of PALB2 disrupts the localisation of BRCA2 to sites of DNA damage, and this disruption prevents BRCA2 from promoting the joining of undamaged homologous repair molecules in HRR. *)
  (* Since we have Loss x ∧ PALB2 x, we can infer the disruption and prevention as described in Explanation 3. *)
  then have "Prevents e1 ∧ Agent e1 y ∧ Promoting e3 ∧ Agent e3 y ∧ Molecules z ∧ Undamaged z ∧ Homologous z ∧ Repair z ∧ HRR z ∧ Joining e3 ∧ Agent e3 z" sledgehammer
  (* We need to show that this prevention is equivalent to the hypothesis statement. *)
  then have "∃x y z e1 e2. Loss x ∧ PALB2 x ∧ Action y ∧ BRCA2 y ∧ Molecules z ∧ Undamaged z ∧ Repair z ∧ HRR z ∧ Prevents e1 ∧ Agent e1 x ∧ Agent e1 y ∧ Joining e2 ∧ Agent e2 y ∧ Agent e2 z" <ATP>
  then show ?thesis <ATP>
qed

end
